SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sharps Compliance Corp. (SMED)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JakeStraw10/31/2014 9:56:14 AM
   of 9
 
Sharps Compliance Reports 12% Increase in Fiscal 2015 First Quarter Revenue
finance.yahoo.com

Pharmaceutical manufacturer market billings increase 129% over prior year first quarter

Retail market billings increase 8% as compared to prior year first quarter

Environmental market billings increase 114% as compared to first quarter of fiscal 2014

Cash balance increases to $16.1 million

David P. Tusa, President and Chief Executive Officer of Sharps, commented, "Once again, we delivered strong quarterly customer billings of $7.5 million led by growth in our Pharmaceutical Manufacturer and Retail markets. Our December 2014 quarter is also looking solid, led by what we believe to be a strong flu shot business and additional orders for existing and new Pharmaceutical Manufacturer programs."

Mr. Tusa stated, "We are in the process of launching a number of new solutions in response to the DEA regulations to implement the Secure and Responsible Drug Disposal Act. This includes not only our MedSafe program but also our new line of TakeAway mailbacks designed to facilitate the cost-effective disposal of unused medications including controlled substances. We believe this new product line has the opportunity to positively impact a number of our key markets including Retail and Assisted Living."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext